Addition of anticancer agents enhances freezing-induced prostate cancer cell death: Implications of mitochondrial involvement

Cryobiology

Volumn 49, Issue 1, 2004, Pages 45-61

  Clarke, Dominic M ^a   Baust, John M ^a   Van Buskirk, Robert G ^a   Baust, John G ^a  

^a BINGHAMTON UNIVERSITY   (United States)

Author keywords

Apoptosis; Bcl 2; Cancer; Chemotherapy; Cryosurgery; Necrosis; Prostate

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; PROTEIN BAX;

ARTICLE; CELL DEATH; CONTROLLED STUDY; FREEZING; HUMAN; HUMAN CELL; MALE; MOLECULAR DYNAMICS; MOLECULAR MODEL; MORPHOLOGY; PRIORITY JOURNAL; PROSTATE CARCINOMA;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL DEATH; CELL LINE, TUMOR; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CRYOSURGERY; FLUOROURACIL; FREEZING; HUMANS; MALE; MITOCHONDRIA; NECROSIS; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 3242681496     PISSN: 00112240     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cryobiol.2004.05.003     Document Type: Article

References (63)

1. Baust J.G., Gage A.A., Ma H., Zhang C. Minimally invasive cryosurgery: technological advances. Cryobiology. 34:1997;373-384
2. Baust J.M., Van Buskirk R.G., Baust J.G. Cell viability improves following inhibition of cryopreservation-induced apoptosis. In Vitro Cell. Dev. Biol. Anim. 36(4):2000;262-270
3. Biswas R.S., Cha H.J., Hardwick J.M., Srivastava R.K. Inhibition of drug-induced Fas ligand transcription and apoptosis by Bcl-xl. Mol. Cell. Biochem. 225:2001;7-20
4. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A. Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. 92(16):1995;7162-7166
5. Bratton S.B., MacFarlane M., Cain K., Cohen G.M. Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis. Exp. Cell Res. 256:2000;27-33
6. Burlacu A., Jinga V., Gafencu A.V., Simionescu M. Severity of oxidative stress generates different mechanisms of endothelial cell death. Cell Tissue Res. 306(3):2001;409-416
7. Clarke D.M., Hollister W.R., Baust J.G., Van Buskirk R.G. Cryosurgical modeling: sequence of freezing and cytotoxic agent application affects cell death. Mol. Urol. 3(1):1999;25-31
8. Clarke D.M., Baust J.M., Van Buskirk R.G., Baust J.G. Chemo-cryo combination therapy: an adjunctive model for the treatment of prostate cancer. Cryobiology. 42:2001;274-285
9. Coffey R., William R., Watson G., Fitzpatrick J.M. Signaling for the caspases: their role in prostate cell apoptosis. J. Urol. 165:2001;5-14
10. Cohen J., Miller R., Rooker G., Shuman B. Cryosurgical ablation of the prostate: two year prostate specific antigen and biopsy results. Urology. 47:1996;395-401
11. Connolly J.A., Shinohara K., Presti J.C. Jr., Carroll P.R. Role of cryosurgery in the treatment of localized prostate cancer. Top. Clin. Urol. 39:1997;143-159
12. Daliani D.D., Eisenberg P.D., Weems J., Lord R., Fueger R., Logothetis C.J. The results of a phase II randomized trial comparing 5-fluorouracil and 5-fluorouracil plus α-interferon: observations on the design of clinical trials for androgen-independent prostate cancer. J. Urol. 153:1995;1587-1591
13. Denecker G., Vercammen D., Declercq W., Vandenabeele P. Apoptotic and necrotic cell death induced by death domain receptors. Cell. Mol. Life Sci. 58:2001;356-370
14. Eguchi Y., Shimizu S., Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 57:1997;1835-1840
15. Finnegan N.M., Curtin J.F., Prevost G., Morgan B., Cotter T.G. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions. Br. J. Cancer. 85(1):2001;115-121
16. Gage A.A., Baust J.G. Mechanisms in tissue injury. Cryobiology. 37:1998;171-186
17. Geiseler F., Nuessler K.V. Apoptosis research is saving the reputation of chemotherapy. Leukemia. 13:1999;1853
18. Geske F.J., Gerschenson L.E. The biology of apoptosis. Human Pathol. 31(10):2001;1029-1038
19. Ghafar M.A., Johnson C.W., De La Taille A., Benson M.C., Bagiella M., Fatal M., Olsson C.A., Katz A.E. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J. Urol. 166:2001;1333-1338
20. Gupta S. Molecular steps of death receptor and mitochondrial pathways of apoptosis. Life Sci. 69:2001;2957-2964
21. Hanai A., Yang W., Ravikumar T.S. Induction of apoptosis in human colon carcinoma cells HT29 by sublethal cryo-injury: mediation by cytochrome c release. Int. J. Cancer. 93:2001;526-533
22. Hannun Y.A. Apoptosis and the dilemma of cancer chemotherapy. J. Am. Soc. Hematol. 89(6):1997;1845-1853
23. Herr I., Debatin M. Cellular stress response and apoptosis in cancer therapy. Blood. 98(9):2001;2603-2614
24. Holleyman C.R., Larson D.F. Apoptosis in the ischemic reperfused myocardium. Perfusion. 16(6):2001;491-502
25. Hollister W.R., Mathew A.J., Baust J.G., Van Buskirk R.G. Effects of freezing on cell viability and mechanisms of cell death in a human prostate cancer cell line. Mol. Urol. 2(1):1998;13-18
26. Howell S.B. Resistance to apoptosis in prostate cancer cells. Mol. Urol. 4(3):2000;225-229
27. Kaufmann S.C., Earnshaw W.C. Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256:2000;42-49
28. Koppie T.M., Shinohara K., Grossfeld G.D., Presti J.C., Carroll P.R. The efficacy of cryosurgical ablation of the prostate cancer: The University of California, San Francisco experience. J. Urol. 162:1999;427-432
29. Lara P.N., Kung H., Gumerlock P.H., Meyers F.J. Molecular biology of prostate cancer. Crit. Rev. Oncol. Hematol. 32:1999;197-208
30. Lee F., Bahn D.K., Badalament R.A., Kumar A.B., Klionsky D., Onik G.M., Chinn D.O., Greene C. Cryosurgery for prostate cancer: Improved glandular ablation by use of 6 to 8 probes. Adult Urol. 54(1):1999;135-140
31. Lee R.H., Song J.M., Park M.Y., Kang S.K., Kim Y.K., Jung J.S. Cisplatin-induced apoptosis by translocation of endogenous Bax in mouse collecting duct cells. Biochem. Pharmacol. 62(8):2001;1013-1023
32. Leist M., Single B., Castoldi A.F., Kuhnle S., Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185(8):1997;1481-1486
33. Li X., Marani M., Mannucci R., Andriani F., Nicoletti I., Denner L., Marcelli M. Overexpression of Bcl-xl underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells. Cancer Res. 61:2001;1699-1706
34. Loeffler M., Kroemer G. The mitochondria in cell death control: certainties and incognita. Exp. Cell Res. 256:2000;19-26
35. Lowe S.W., Lin A.W. Apoptosis in cancer. Carcinogenesis. 21(3):2000;485-495
36. Mackey T.J., Borkowski A., Amin P., Jacobs S.C., Kyprianou N. Bcl-2/Bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer. Urology. 52(6):1998;1085-1089
37. Mailloux A., Grenet K., Bruneel A., Beneteau-Burnat B., Vaubourdolle M., Baudin B. Anticancer drugs induce necrosis of human endothelial cells involving both oncosis and apoptosis. Eur. J. Cell Biol. 80(6):2001;442-449
38. Mazur P. Freezing of living cells: mechanisms and implications. Am. J. Physiol. 247(3 pt 1):1984;C125-C142
39. Mazur P. Physical-chemical factors underlying cell injury in cryosurgical freezing. Rand R., Rinfret A., Von Leden H. Cryosurgery. 1968;32-51 Thomas, Springfield, IL
40. Meilhac O., Escargueil-Blanc I., Theirs J., Salvayre R., Negre-Salvayre A. Bcl-2 alters the balance between apoptosis and necrosis, but does not prevent cell death induced by oxidized low density lipoproteins. FASEB. 13:1999;485-494
41. Melino G., Catani M.V., Corazzari M., Guerrieri P., Bernassola F. Nitric oxide can inhibit apoptosis or switch it into necrosis. CMLS. 57:2000;612-622
42. Miller R.J., Cohen J.K. A closer look at cryosurgical ablation of the prostate. Contemp. Urol. 15:1998;10-21
43. Millikan R.E. Urinary carcinomas: carcinoma of the prostate. Foley J.F., Vose J.M., Armitage J.O. Current Therapy in Cancer. 1999;175-183 W.B. Saunders, New York, NY
44. Mirjolet J.P., Barberi-Heyob M., Didelot C., Peyrat J.P., Abecassis J., Millon R., Merlin J.L. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status. Br. J. Cancer. 10(10):2000;1380-1386
45. Munshi A., Pappas G., Honda T., McDonnell T.J., Younes A., Li Y., Meyn R.E. TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2. Oncogene. 20:2001;3757-3765
46. Nita M.E., Nagawa H., Tominaga O., Tsuno N., Fujii S., Sasaki S., Fu C.-G., Takenoue T., Tsurou T., Muto T. 5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins. Br. J. Cancer. 78(8):1998;986-992
47. Onik G. Cryosurgery. Crit. Rev. Oncol./Hematol. 23:1996;1-24
48. Onik G.M., Cohen J.K., Reyes G.D., Rubinsky B., Chang Z., Baust J. Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer. 72(4):1993;1291-1299
49. Patel B.G., Parsons C.L., Bidair M., Schmidt J.D. Cryoablation for carcinoma of the prostate. J. Surg. Oncol. 63:1996;256-264
50. Pelisek J., Armeanu S., Nikol S. Quiescence, cell viability, apoptosis and necrosis of smooth muscle cells using different growth inhibitors. Cell Prolif. 34:2001;305-320
51. Raghavan D., Koczwara B., Javle M. Clinical oncology update: Prostate cancer. Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer. Eur. J. Cancer. 33(4):1997;566-574
52. Raffo A.J., Perlman H., Chen M.W., Day M.L., Streitman J.S., Buttyan R. Overexpression of Bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res. 55(19):1995;4438-4445
53. Saliken J.C., Donnelly B.J., Ernst S., Rewcastle J., Wiseman D. Prostate cryotherapy: practicalities and applications from the Calgary experience. Can. Assoc. Radiol. J. 523:2001;165-173
54. Shimizu S., Eguchi Y., Kamiike W., Waguri S., Uchiyama Y., Matsuda H., Tsujimoto Y. Retardation of chemical hypoxia-induced necrotic cell death by bcl-2 and ICE inhibitors: possible involvement of common mediators in apoptotic and necrotic transductions. Oncogene. 12(10):1996;2045-2050
55. Shinoura N., Yoshida Y., Nishimura M., Muramatsu Y., Asai A., Kirino T., Hamada H. Relative level of expression of Bax and Bcl-Xl determines the cellular fate of apoptosis/necrosis induced by the overexpression of Bax. Oncogene. 18:1999;5703-5713
56. Single B., Leist M., Nicotera P. Differential effects of Bcl-2 on cell death triggered under ATP-depleting conditions. Exp. Cell Res. 26:2001;8-16
57. Stegh A.H., Peter M.E. Apoptosis and caspases. Cardiovasc. Dis. 19(1):2001;13-29
58. Tsujimoto Y. Apoptosis and necrosis: intracellular ATP level as a determinant for cell death modes. Cell Death Differ. 4:1997;429-434
59. Van Brussel J.P., Van Steenbrugge G.J., Van Krimpen C., Bogdanowicz J., Van Der Kwast T.H., Schroder F.H., Mickisch G.H. Expression of multidrug resistance related proteins and proliferative activity is increased in advanced clinical prostate cancer. J. Urol. 165:2001;130-135
60. Vincenz C. Death receptors and apoptosis: deadly signaling and evasive tactics. Cardiovasc. Dis. 19(1):2001;31-43
61. Wyllie A.H., Kerr J.F., Currie A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:1980;251-306
62. Zangemeister-Wittke U., Simon H. Apoptosis-regulation and clinical implications. Cell Death Differ. 8:2001;537-544
63. Znati C.A., Werts E., Kociban D., Kalnicki S. Variables influencing response of human prostate carcinoma cells to combined radiation and cryotherapy in vitro. Cryobiology. 37(4):1998;450-451